Amplification of cytokine production through synergistic activation of NFAT and AP-1 following stimulation of mast cells with antigen and IL-33

European Journal of Immunology

Volumn 41, Issue 3, 2011, Pages 760-772

  Andrade, Marcus V ^a,b   Iwaki, Shoko ^a   Ropert, Catherine ^c   Gazzinelli, Ricardo T ^c   Cunha Melo, Jose R ^b   Beaven, Michael A ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Ag; Cytokine; IL 33; Mast Cells; Signaling mechanisms

Indexed keywords

CALCINEURIN; CALCIUM; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 33; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; THAPSIGARGIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NFAT; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNE DISEASE; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME ACTIVITY; IMMUNE RESPONSE; INFLAMMATION; INTRACELLULAR SIGNALING; MAST CELL; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANIMALS; ANTIGENS; CALCINEURIN; CALCIUM; CELL LINE; CYTOKINES; INTERLEUKINS; MAST CELLS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, IMMUNOLOGICAL; MYELOID DIFFERENTIATION FACTOR 88; NFATC TRANSCRIPTION FACTORS; RATS; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC;

EID: 79951803284     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201040718     Document Type: Article

References (56)

1. Beaven, M. A., Our perception of the mast cell from Paul Ehrlich to now. Eur. J. Immunol. 2009. 39: 11-25.
2. Kalesnikoff, J. and Galli, S. J., New developments in mast cell biology. Nat. Immunol. 2008. 9: 1215-1223.
3. Kuehn, H. S. and Gilfillan, A. M., G protein-coupled receptors and the modification of FcεRI-mediated mast cell activation. Immunol. Lett. 2007. 113: 59-69.
4. Qiao, H., Andrade, M. V., Lisboa, F. A., Morgan, K. and Beaven, M. A., FceRI and Toll-like receptors mediate synergistic signals to markedly augment production of inflammatory cytokines in murine mast cells. Blood 2006. 107: 610-618.
5. Galli, S. J., Kalesnikoff, J., Grimbaldeston, M. A., Piliponsky, A. M., Williams, C. M. and Tsai, M., Mast cells as "tunable" effector and immunoregulatory cells: Recent Advances. Annu. Rev. Immunol. 2005. 23: 749-786.
6. Gilfillan, A. M. and Tkaczyk, C., Integrated signalling pathways for mast-cell activation. Nat. Rev. Immunol. 2006. 6: 218-230.
7. Rivera, J. and Gilfillan, A. M., Molecular regulation of mast cell activation. J. Allergy Clin. Immunol. 2006. 117: 1214-1225.
8. Abramson, J. and Pecht, I., Regulation of the mast cell response to the type 1 Fcε receptor. Immunol. Rev. 2007. 217: 231-254.
9. 2+ and purified isozymes in washed permeabilized cells. J. Biol. Chem. 1993. 268: 1749-1756.
10. 2+ signaling with particular focus on mast cells. Crit. Rev. Immunol. 2009. 29: 155-186.
11. Kalesnikoff, J., Baur, N., Leitges, M., Hughes, M. R., Damen, J. E., Huber, M. and Krystal, G., SHIP negatively regulates IgE+antigen-induced IL-6 production in mast cells by inhibiting NFκB activity. J. Immunol. 2002. 168: 4737-4746.
12. Hundley, T. R., Gilfillan, A. M., Tkaczyk, C., Andrade, M. V., Metcalfe, D. D. and Beaven, M. A., Kit and FcεRI mediate unique and convergent signals for release of inflammatory mediators from human mast cells. Blood 2004. 104: 2410-2417.
13. Allakhverdi, Z., Smith, D. E., Comeau, M. R. and Delespesse, G., Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells. J. Immunol. 2007. 179: 2051-2054.
14. Iikura, M., Suto, H., Kajiwara, N., Oboki, K., Ohno, T., Okayama, Y., Saito, H., Galli, S. J. and Nakae, S., IL-33 can promote survival, adhesion and cytokine production in human mast cells. Lab Invest. 2007. 87: 971-978.
15. Ho, L. H., Ohno, T., Oboki, K., Kajiwara, N., Suto, H., Iikura, M., Okayama, Y. et al., IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcεRI signals. J. Leukoc. Biol. 2007. 82: 1481-1490.
16. Moulin, D., Donze, O., Talabot-Ayer, D., Mezin, F., Palmer, G. and Gabay, C., Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells. Cytokine 2007. 40: 216-225.
17. Pecaric-Petkovic, T., Didichenko, S. A., Kaempfer, S., Spiegl, N. and Dahinden, C. A., Human basophils and eosinophils are the direct target leukocytes of the novel IL-1-family member IL-33. Blood 2009. 113: 1526-1534.
18. Kroeger, K. M., Sullivan, B. M. and Locksley, R. M., IL-18 and IL-33 elicit Th2 cytokines from basophils via a MyD88- and p38α-dependent pathway. J. Leukoc. Biol. 2009. 86: 769-778.
19. h2 cells, iNKT and NK cells. Int. Immunol. 2008. 20: 1019-1030.
20. Suzukawa, M., Iikura, M., Koketsu, R., Nagase, H., Tamura, C., Komiya, A., Nakae, S. et al., An IL-1 cytokine member, IL-33, induces human basophil activation via its ST2 receptor. J. Immunol. 2008. 181: 5981-5989.
21. Silver, M. R., Margulis, A., Wood, N., Goldman, S. J., Kasaian, M. and Chaudhary, D., IL-33 synergizes with IgE-dependent and IgE-independent agents to promote mast cell and basophil activation. Inflamm. Res. 2010. 59: 207-218.
22. Carriere, V., Roussel, L., Ortega, N., Lacorre, D. A., Americh, L., Aguilar, L., Bouche, G. and Girard, J. P., IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc. Natl. Acad. Sci. USA 2007. 104: 282-287.
23. Pushparaj, P. N., Tay, H. K., H'ng, S. C., Pitman, N., Xu, D., McKenzie, A., Liew, F. Y. and Melendez, A. J., The cytokine interleukin-33 mediates anaphylactic shock. Proc. Nat. Acad. Sci. USA 2009. 106: 9773-9778.
24. Xu, D., Jiang, H. R., Kewin, P., Li, Y., Mu, R., Fraser, A. R., Pitman, N. et al., IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proc. Natl. Acad. Sci. USA 2008. 105: 10913-10918.
25. Liew, F. Y., Pitman, N. I. and McInnes, I. B., Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat. Rev. Immunol. 2010. 10: 103-110.
26. Smith, D. E., IL-33: a tissue derived cytokine pathway involved in allergic inflammation and asthma. Clin. Exp. Allergy 2010. 40: 200-208.
27. Theoharides, T. C., Zhang, B., Kempuraj, D., Tagen, M., Vasiadi, M., Angelidou, A., Alysandratos, K. D. et al., IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin. Proc. Natl. Acad. Sci. USA 2010. 107: 4448-4453.
28. Xu, D., Jiang, H. R., Li, Y., Pushparaj, P. N., Kurowska-Stolarska, M., Leung, B. P., Mu, R. et al., IL-33 exacerbates autoantibody-induced arthritis. J. Immunol. 2010. 184: 2620-2626.
29. Hsu, C.-L., Neilsen, C. V. and Bryce, P. J., IL-33 is produced by mast cells and regulates IgE-dependent inflammation. PLoS One 2010. 5: e11944.
30. Arend, W. P., Palmer, G. and Gabay, C., IL-1, IL-18, and IL-33 families of cytokines. Immunol. Rev. 2008. 223: 20-38.
31. Chackerian, A. A., Oldham, E. R., Murphy, E. E., Schmitz, J., Pflanz, S. and Kastelein, R. A., IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. J. Immunol. 2007. 179: 2551-2555.
32. Ali, S., Huber, M., Kollewe, C., Bischoff, S. C., Falk, W. and Martin, M. U., IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells. Proc. Natl. Acad. Sci. USA 2007. 104: 18660-18665.
33. Palmer, G., Lipsky, B. P., Smithgall, M. D., Meininger, D., Siu, S., Talabot-Ayer, D., Gabay, C. and Smith, D. E., The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33. Cytokine 2008. 42: 358-364.
34. Gadina, M. and Jefferies, C. A., IL-33: a sheep in wolf's clothing? Sci. STKE 2007. 2007: e31.
35. Kakkar, R. and Lee, R. T., The IL-33/ST2 pathway: therapeutic target and novel biomarker. Nat. Rev. Drug Discov. 2008. 7: 827-840.
36. Schmitz, J., Owyang, A., Oldham, E., Song, Y., Murphy, E., McClanahan, T. K., Zurawski, G. et al., IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005. 23: 479-490.
37. Ninomiya-Tsuji, J., Kishimoto, K., Hiyama, A., Inoue, J., Cao, Z. and Matsumoto, K., The kinase TAK1 can activate the NIK-IκB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature 1999. 398: 252-256.
38. Jiang, Z., Ninomiya-Tsuji, J., Qian, Y., Matsumoto, K. and Li, X., Interleukin-1 (IL-1) receptor-associated kinase-dependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosol. Mol. Cell Biol. 2002. 22: 7158-7167.
39. Shim, J. H., Xiao, C., Paschal, A. E., Bailey, S. T., Rao, P., Hayden, M. S., Lee, K. Y. et al., TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo. Genes Dev. 2005. 19: 2668-2681.
40. Matsuyama, Y., Okazaki, H., Tamemoto, H., Kimura, H., Kamata, Y., Nagatani, K., Nagashima, T. et al., Increased levels of interleukin 33 in sera and synovial fluid from patients with active rheumatoid arthritis. J. Rheumatol. 2010. 37: 18-25.
41. Moritz, D. R., Rodewald, H. R., Gheyselinck, J. and Klemenz, R., The IL-1 receptor-related T1 antigen is expressed on immature and mature mast cells and on fetal blood mast cell progenitors. J. Immunol. 1998. 161: 4866-4874.
42. Razin, E., Szallasi, Z., Kazanietz, M. G., Blumberg, P. M. and Rivera, J., Protein kinase C-β and C-ε link the mast cell high-affinity receptor for IgE to the expression of c-fos and c-jun. Proc. Natl. Acad. Sci. USA 1994. 91: 7722-7726.
43. Su, T. T., Guo, B., Kawakami, Y., Sommer, K., Chae, K., Humphries, L. A., Kato, R. M. et al., PKC-β controls IκB kinase lipid raft recruitment and activation in response to BCR signaling. Nat. Immunol. 2002. 3: 780-786.
44. Hayden, M. S. and Ghosh, S., Shared principles in NF-κB signaling. Cell 2008. 132: 344-362.
45. Cissel, D. S., Fraundorfer, P. F. and Beaven, M. A., Thapsigargin-induced secretion is dependent on activation of a cholera toxin-sensitive and a phosphatidylinositol-3-kinase-regulated phospholipase D in a mast cell line. J. Pharmacol. Exp. Ther. 1998. 285: 110-118.
46. Mascarell, L. and Truffa-Bachi, P., New aspects of cyclosporin a mode of action: from gene silencing to gene up-regulation. Mini Rev. Med. Chem. 2003. 3: 205-214.
47. Ninomiya-Tsuji, J., Kajino, T., Ono, K., Ohtomo, T., Matsumoto, M., Shiina, M., Mihara, M. et al., A resorcylic acid lactone, 5Z-7-oxozeaenol, prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase. J. Biol. Chem. 2003. 278: 18485-18490.
48. Sato, S., Sanjo, H., Takeda, K., Ninomiya-Tsuji, J., Yamamoto, M., Kawai, T., Matsumoto, K. et al., Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat. Immunol. 2005. 6: 1087-1095.
49. Klemm, S., Gutermuth, J., Hültner, L., Sparwasser, T., Behrendt, H., Peschel, C., Mak, T. W. et al., The Bcl10-Malt1 complex segregates FcεRI-mediated nuclear factor-κB activation and cytokine production from mast cell degranulation. J. Exp. Med. 2006. 203: 337-347.
50. Sun, L., Deng, L., Ea, C. K., Xia, Z. P. and Chen, Z. J., The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol. Cell 2004. 14: 289-301.
51. Loots, G. G. and Ovcharenko, I., rVISTA 2.0: evolutionary analysis of transcription factor binding sites. Nucleic Acids Res. 2004. 32: W217-W221.
52. Loots, G. G. and Ovcharenko, I., Mulan: multiple-sequence alignment to predict functional elements in genomic sequences. Methods Mol. Biol. 2007. 395: 237-254.
53. Mácian, F., López-Rodriguez, C. and Rao, A., Partners in transcription: NFAT and AP-1. Oncogene 2001. 20: 2476-2489.
54. de Lumley, M., Hart, D. J., Cooper, M. A., Symeonides, S. and Blackburn, J. M., A biophysical characterisation of factors controlling dimerisation and selectivity in the NF-κB and NFAT families. J. Mol. Biol. 2004. 339: 1059-1075.
55. Macian, F., Garcia-Rodriguez, C. and Rao, A., Gene expression elicited by NFAT in the presence or absence of cooperative recruitment of Fos and Jun. EMBO J. 2000. 19: 4783-4795.
56. Iwaki, S., Tkaczyk, C., Satterthwaite, A. B., Halcomb, K., Beaven, M. A., Metcalfe, D. D. and Gilfillan, A. M., Btk plays a crucial role in the amplification of FcεRI-mediated mast cell activation by Kit. J. Biol. Chem. 2005. 280: 40261-40270.